Zobrazeno 1 - 10
of 961
pro vyhledávání: '"Ferran, Torres"'
Autor:
José Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros, María Reig, Ferran Torres, Caridad Pontes
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 389-401 (2024)
Abstract Background and Objectives Direct-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of cancer after HCV eradication remain. Our study aimed at quantifying the incidence of cancer
Externí odkaz:
https://doaj.org/article/34e92b905d0847f391b867ed2b47fb9f
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
With a global increased use of psychotropics in pediatrics, their off-label use is a concern due to uncertainty and risk. Data on psychotropics use in the Greek pediatric population do not exist to date. We analyzed retrospective data from the nation
Externí odkaz:
https://doaj.org/article/5306629e850c489aa957bb77e25f79b1
Autor:
Joaquín Sáez-Peñataro, Gonzalo Calvo, Juan Bascuas, Maria Mar Mosquera, Maria Ángeles Marcos, Natalia Egri, Ferran Torres
Publikováno v:
Vaccines, Vol 12, Iss 6, p 665 (2024)
Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel vaccines aimed at augmenting immune protection while minimising reactogenic responses. Before this design is carried out, it is important to determine whether adap
Externí odkaz:
https://doaj.org/article/6f64ad77e92a49b095b26ce974a54597
Autor:
Dan Ouchi, Carles Vilaplana-Carnerero, Ramon Monfà, Maria Giner-Soriano, Ana Garcia-Sangenís, Ferran Torres, Rosa Morros
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 447-457 (2023)
Abstract Background Type 2 diabetes mellitus is a chronic disease affecting millions of people worldwide. Achieving and maintaining glycemic control is essential to prevent or delay complications and different strategies are available as second-line
Externí odkaz:
https://doaj.org/article/4e92e3c7c21043fcbea1982f4c3b5a1a
Autor:
David Elvira, Ferran Torres, Roser Vives, Gemma Puig, Mercè Obach, Daniel Gay, Daniel Varón, Thais de Pando, Josep Tabernero, Caridad Pontes
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionEven using well-established technology assessment processes, the basis of the decisions on drug price and reimbursement are sometimes perceived as poorly informed and sometimes may be seen as disconnected from value. The literature remain
Externí odkaz:
https://doaj.org/article/c0c6fd588b57467b97b8226c53b556ce
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Psychotropics are increasingly used in pediatrics, often as off-label medicines. The guarantees of safety and efficacy are not always granted in clinical practice compared to adult authorised indications. A retrospective observational study was done
Externí odkaz:
https://doaj.org/article/6f8d34c81fd849c5b5ee33280d83de1d
Autor:
Giuseppe Cabibbo, Maria Reig, Ciro Celsa, Ferran Torres, Salvatore Battaglia, Marco Enea, Giacomo Emanuele Maria Rizzo, Salvatore Petta, Vincenza Calvaruso, Vito Di Marco, Antonio Craxì, Amit G. Singal, Jordi Bruix, Calogero Cammà
Publikováno v:
Liver Cancer, Pp 1-10 (2021)
Introduction: Atezolizumab (ATEZO) plus bevacizumab (BEVA) represents the new standard of care for the treatment of advanced hepatocellular carcinoma (HCC). However, the choice of the second-line treatment after the failure of immunotherapy-based fir
Externí odkaz:
https://doaj.org/article/49f9c3951aad466793506f22ced773ef
Autor:
Dan Ouchi, Maria Giner-Soriano, Ainhoa Gómez-Lumbreras, Cristina Vedia Urgell, Ferran Torres, Rosa Morros
Publikováno v:
JMIR Medical Informatics, Vol 10, Iss 11, p e37976 (2022)
BackgroundSince the use of electronic health records (EHRs) in an automated way, pharmacovigilance or pharmacoepidemiology studies have been used to characterize the therapy using different algorithms. Although progress has been made in this area for
Externí odkaz:
https://doaj.org/article/860ea7b6db1849bf8bd4c07591eabf9d
Autor:
Salvatore Rudilosso, José Ríos, Alejandro Rodríguez, Meritxell Gomis, Víctor Vera, Manuel Gómez-Choco, Arturo Renú, Núria Matos, Laura Llull, Francisco Purroy, Sergio Amaro, Mikel Terceño, Víctor Obach, Joaquim Serena, Joan Martí-Fàbregas, Pedro Cardona, Carlos Molina, Ana Rodríguez-Campello, David Cánovas, Jerzy Krupinski, Xavier Ustrell, Ferran Torres, Luis San Román, Mercè Salvat-Plana, Francesc Xavier Jiménez-Fàbrega, Ernest Palomeras, Esther Catena, Carla Colom, Dolores Cocho, Juanjo Baiges, Josep Maria Aragones, Gloria Diaz, Xavier Costa, María Cruz Almendros, Maria Rybyeba, Miquel Barceló, Dolors Carrión, Matilde Núria Lòpez, Eduard Sanjurjo, Natalia Pérez de la Ossa, Xabier Urra, Ángel Chamorro, for the Catalan Stroke Code and Reperfusion (Cat-SCR) Consortium
Publikováno v:
Journal of Stroke, Vol 23, Iss 3, Pp 401-410 (2021)
Background and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment strati
Externí odkaz:
https://doaj.org/article/47d3e77dd8e84eafa09303c06d53a80b
Autor:
Robin W. M. Vernooij, Way Law, Sanne A. E. Peters, Bernard Canaud, Andrew Davenport, Muriel P. C. Grooteman, Fatih Kircelli, Francesco Locatelli, Francisco Maduell, Marion Morena, Menso J. Nubé, Ercan Ok, Ferran Torres, Mark Woodward, Peter J. Blankestijn, Michiel L. Bots, on behalf of the HDF Pooling project investigators
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Due to a critical shortage of available kidney grafts, most patients with Stage 5 Chronic Kidney Disease (CKD5) require bridging dialysis support. It remains unclear whether treatment by different dialysis modalities changes the s
Externí odkaz:
https://doaj.org/article/da625d1b4cb4492bb4be2862cc08ce14